health MEL-SELF Trial Reveals Confidence Gaps in Melanoma Self-Examination
New baseline data from Australia's MEL-SELF trial shows 20% of melanoma survivors hadn't performed skin self-exams in a year-and 46% reported clinically significant fear of cancer recurrence.
